Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.

Inclusion Criteria: * Areas for which cellulite appearance reduction is being sought are the bilateral thighs and buttocks * Clinical cellulite gradation of Stage II or III on the Nurnberger-Muller scale for each treatment area * PI or P2 on the American Society of Anesthesiologists (ASA) Physical Status Classification System * Willing and able to abstain from partaking in any treatment other than the study procedure to promote cellulite appearance reduction/body contouring/weight loss during the study * Willing and able to maintain regular diet and exercise regimen without effecting significant change in either direction during the study * Willing and able to maintain regular medication schedule, as is medically feasible, during the study Exclusion Criteria: * Clinical cellulite gradation of Stage 0 or I on the Nurnberger Muller Scale (NMS) for either one or both thighs/buttocks * P3 or P4 or P5 or P6 on the ASA Physical Status Classification System * Weight fluctuation greater than 10 pounds in the prior month * Previous attempt(s) to reduce cellulite in the study treatment areas over the past 6 months * Prior surgical intervention to the treatment areas, for any reason * Medical, physical or other contraindications for cellulite reduction/body contouring/weight loss * Current use of medication(s) known to affect weight levels and/or cause bloating or swelling and for which abstinence during the study is not safe or medically prudent * Any medical condition known to affect weight levels, cause bloating or swelling * Diagnosis of, and/or taking medication for, irritable bowel syndrome * Active infection, wound or other external trauma to the study treatment areas * Dermatitis or significant scarring in the study treatment areas * Medical, physical, or other contraindications for, or known sensitivity to, light therapy * Diabetes dependent on insulin or oral hypoglycemic medications * Known cardiovascular disease * Cardiac surgeries * History of deep venous thrombosis, arterial disease of the legs * Pregnant, breast feeding, or planning pregnancy prior to study end * Serious mental health illness or psychiatric hospitalization in past 2 years * Developmental disability or cognitive impairment that would impact study participation * Involved in litigation/receiving disability benefits related to the parameters of the study * Participation in research in the past 30 days